Genome-wide analysis of mouse myeloma cell lines expressing therapeutic antibodies

Biotechnology Progress

Volumn 23, Issue 4, 2007, Pages 911-920

  Dorai, Haimanti ^a   Li, Katherine ^a   Huang, C Chris ^a   Bittner, Anton ^b   Galindo, Jose ^b   Carmen, Andrew ^b  

^a CENTOCOR INC   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOTECHNOLOGY; CELL GROWTH; CELLS;

CELLULAR GENES; SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI); THERAPEUTIC ANTIBODY; TRANSFECTOMAS;

GENES;

ANTIBODY;

ANIMAL; ARTICLE; BIOTECHNOLOGY; CHEMISTRY; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; MULTIPLE MYELOMA; NEOPLASM; TUMOR CELL LINE;

ANIMALS; ANTIBODIES; BIOTECHNOLOGY; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; MICE; MULTIPLE MYELOMA; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 34547901820     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp0700051     Document Type: Article

References (40)

1. Ganguly, S.; Jin, S. Mammalian expression systems. In Gene Cloning and Expression Technologies; Weiner, M. P., Lu, Q., Eds.; Eaton Publishing: Westborough, MA, 2002; pp 115-141.
2. Trill, J. J. Mammalian expression systems. In Gene Cloning and Expression Technologies; Weiner, M. P., Lu, Q., Eds.; Eaton Publishing: Westborough, MA, 2002; pp 143-162.
3. Wurm, F. M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 2004, 22, 1393-1398.
4. Brewer, J. W.; Hendershot, L. M. Building an antibody factory: a job for the unfolded protein response. Nat. Immunol. 2005, 6, 23-29.
5. Hayduk, E. J.; Lee, K. H. Cytochalasin D can improve heterologous protein productivity in adherent CHO cells. Biotechnol. Bioeng. 2005, 90, 354-364.
6. Lee, M. W.; Park, S. C.; Chae, H. S.; Bach, J. H.; Lee, H. J.; Lee, S. H.; Kang, Y. K.; Kim, K. Y.; Lee, W. B.; Kim, S. S. The protective role of HSP90 against 3-hydroxykynurenine-induced neuronal apoptosi. Biochem. Biophys. Res. Commun. 2001, 284 (2), 261-267.
7. Ertola, R. J.; Giulieti, A. M.; Castillo, F. J. Design, formulation and optimization of media. Bioprocess Technol. 1995, 21, 89-137.
8. Altshuler, G. L.; Dziewulski, D. M.; Sowek, J. A.; Belfort, G. Continuous hybridoma growth and monoclonal antibody production in hollow fiber reactor. Biotechnol. Bioeng. 1986, 28, 646-658.
9. Bibila, T.; Robinson, D. K. In pursuit of the optimal fed-batch process for monoclonal antibody protection. Biotechnol. Prog. 1995, 11, 1-13.
10. Mazur, X.; Fusseneger, M.; Renner, W. A.; Bailey, J. E. Higher productivity of growth arrested Chinese Hamster Ovary cells expressing cyclin dependent kinase inhibitor, p27. Biotechnol. Prog. 1998, 14, 705-715.
11. Pendse, G. J.; Bailey, J. E. Effects of growth factors on cell proliferation and monoclonal antibody production of batch hybridoma cultures. Biotechnol. Lett. 1990, 7, 487-492.
12. Figueroa, B.; Chen, S.; Oyler, G. A.; Hardwick, J. M.; Betenbaugh, M. J. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Biotechnol. Bioeng. 2004, 85, 589-600.
13. Chiang, G. G.; Sisk, W. P. Bcl-XL mediates increased production of humanized monoclonal antibodies in CHO cells. Biotechnol. Bioeng. 2005, 91, 779-791.
14. Dorai, H.; Csirke, B.; Scallon, B.; Ganguly, S. Correlation of Heavy and Light chain mRNA copy numbers to antibody productivity in mouse myeloma production cell lines. Hybridoma 2006, 25, 1-9.
15. Oh, M. K.; Liao, J. C. Gene expression profiling by DNA microarrays and metabolic fluxes in E. coli. Biotechnol. Prog. 2000, 16, 279-286.
16. DeRisi, J. L.; Lyer, V. R.; Brown, P. O. Exploring the metabolic and genomic control of gene expression on a genomic scale. Science 1997, 278, 680-686.
17. Webb, G. C.; Akbar, M. S.; Zhao, C.; Steiner, D. S. Expression profiling of pancreatic b cells: glucose regulation of secretory and metabolic pathway genes. Proc. Natl. Acad Sci. U.S.A. 2000, 97, 5773-5778.
18. Cao, S. X.; Dhahbi, J. M.; Mote, P. L.; Spindler, S. R. Genomic profiling of short and long-term caloric restriction effects in the liver of aging mice. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 10630-10635.
19. Syed, F.; Pannettieri, R. A.; Tliba, O.; Huang, C.; Li, K.; Bracht, M.; Amegadzie, B.; Griswold, D.; Li, L.; Amrani, Y. The effect of IL-13 and IL13130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir. Res. 2005, 6 (9), 1-9.
20. Shen, D.; Sharfstein, S. Genome-wide analysis of the transcriptional response of murine hybridomas to osmotic shock. Biotechnol. Bioeng. 2006, 93, 132-145.
21. Knight, D. M.; Trinh, H.; Le, J.; Siegel, S.; Shealy, D.; McDonough, M, Scallon, B.; Moore, M. A.; Vilckeck, J.; Daddonna, P. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol. Immunol. 1993, 30, 1443-1453.
22. Luo, L.; Salunga, R. C.; Guo, H.; Bittner, A.; Joy, K. C.; Galindo, J. E.; Xiao, H.; Rogers, K. E.; Wan, J. S.; Jackson, M. R.; Erlander, M. G. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat. Med. 1999, 5, 117-122.
23. RT-PCR protocols. In Methods in Molecular Biology; O'Connell, J., Ed.; Humana Press: Totowa, NJ, 2002; Vol. 193, p 378.
24. Meents, H.; Enenkel, B.; Werner, R. G.; Fusseneger, M. p27Kip1-mediated controlled proliferation technology increases constitutive sICAM production in CHO-DUKX adapted for growth in suspension and serum-free media. Biotechnol. Bioeng. 2002, 79, 619-627.
25. Fussenegger, M.; Schlatter, S.; Datwyler, D.; Mazu, X.; Bailey, J. E. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese Hamster Ovary cells. Nat. Biotechnol. 1998, 16, 416-417.
26. Brand, H.; Fraud, S. J.; Metcalf, H. K.; Onadipe, K.; Shaw, A.; Westlake, A. J. Selection strategies for highly productive recombinant mammalian cell lines. In Animal Cell Technology; Butterworth: Woburn, MA, 1994; p 55.
27. Hateboer, G.; Wobst, A.; Petersen, B. O.; Le Cam, L.; Vigo, E.; Sardet, C.; Helin, K. Cell cycle regulated expression of mammalian Cdc6 is dependent on E2F. Mol. Cell. Biol. 1998, 18, 6679-6697.
28. Ohtani, K.; Tsujimoto, K.; Ikeda, M.; Nakamura, M. Regulation of cell growth dependent expression of mammalian Cdc6 gene by cell cycle transcription factor E2F. Oncogene 1998, 8, 1777-1785.
29. Lau, E.; Zhu, C.; Abraham, R. T.; Jiang, W. The functional role of Cdc6 in S-G2/M in mammalian cells. EMBO Rep. 2006, 7 (4), 425-430.
30. Berger, C.; Strub, A.; Staib, C.; Lepke, M.; Zisimopoulous, P.; Hoehn, K.; Nanda, I.; Schmid, M.; Grummt, F. Identification and characterization of a mouse homolog to yeast Cdc6p. Cytogenet. Cell Genet. 1999, 86, 307-316.
31. Gonzalez, S.; Klatt, P.; Delgado, S.; Conde, E.; Lopez-Rios, F.; Sanchez, M.; Serrano, M. Oncogenic activity of Cdc6 through repression of theINK4/ARF locus. Nature 2006, 7084, 702.
32. Zitnik, R. J.; Zhang, J.; Kashem, M. A.; Kohno, T.; Lyons, D. E.; Wright, C. D.; Rosen, E.; Goldberg, I.; Hayday, A. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. Biochem. Biophys. Res. Commun. 1997, 232, 687-697.
33. Devoogdt, N.; Ghassabeh, G. H.; Zhang, J.; Brys, L.; De Baetselier, P.; Revets, H. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc. Nat. Acad. Sci. U.S.A. 2003, 100, 5778-5782.
34. Zhang, D.; Simmen, R. C. M.; Michel, F. J.; Zhao, G.; Vale-Cruz, D. Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J. Biol. Chem. 2002, 277, 29999-30009.
35. Hiemstra, P. S. Novel roles of protease inhibitors in infecton and inflammation. Biochem. Soc. Trans. 2002, 30 (2), 116-120.
36. Velarde, M. C.; Parisek, S. I.; Eason, R. R.; Simmen, F. A.; Simmen, R. C. The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells. J. Endocrinol. 2005, 184, 141-151.
37. Kikuchi, T.; Abe, T.; Yaekashiwa, M.; Tominaga, Y.; Mitsuhashi, H.; Satoh, K.; Nakamract; Nukiwa, T. Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 2000, 23, 364-370.
38. Zhang, Y.; DeWitt, D. L.; McNeely, T. B.; Wahl, S. M.; Wahl, L. M. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthesase-2, prostaglandin E2, and matrix metalloproteinase. J. Clin. Invest. 1997, 99, 894-900.
39. Betts, J. I.; Baganz, F. Miniature bioreactors: Current practices and future opportunities. Microb. Cell Factories 2006, 5, 21.
40. Barnes, L. M.; Bentley, C. M.; Dickson, A. J. Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells. Biotechnol. Bioeng. 2004, 85, 115.